STOCK TITAN

Smartkem SEC Filings

SMTK NASDAQ

Welcome to our dedicated page for Smartkem SEC filings (Ticker: SMTK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

SmartKem, Inc. (NASDAQ: SMTK) files reports with the U.S. Securities and Exchange Commission that provide detailed information on its organic semiconductor business, financial condition, capital structure and strategic initiatives. On this page, investors can review SMTK’s 8-K current reports, quarterly and annual filings, and other disclosures, with AI-powered tools that summarize key points and explain complex sections.

Recent Form 8-K filings describe several material events, including a non-binding Letter of Intent with Jericho Energy Ventures for a proposed all-stock business combination to create a U.S.-owned AI-focused infrastructure company, amendments to prior financing agreements, and a securities purchase agreement for senior secured notes and warrants that are secured by substantially all of the company’s assets. Other 8-Ks discuss equity awards to executives and directors, a Nasdaq notice regarding non-compliance with minimum stockholders’ equity requirements, the company’s decision to consider strategic alternatives, and a press release announcing a preliminary joint development agreement with Manz Asia.

SmartKem’s filings also include current reports on financial results, such as the press release for its quarter ended September 30, 2025, where it notes revenue from sales of OTFT backplanes and TRUFLEX materials for customer assessment and development purposes, as well as operating expenses and net loss figures. Additional disclosures explain that the company has curtailed operations and delayed vendor payments due to capital constraints and will require significant additional capital to resume normal operations.

Through this SEC filings page, users can access SmartKem’s 10-Q and 10-K reports (when available), proxy and governance documents, and Form 4 insider transaction reports. AI-generated summaries help highlight topics such as revenue sources, R&D spending on TRUFLEX and OTFT technologies, Nasdaq listing compliance, debt and warrant terms, and the status of the proposed Jericho transaction, allowing readers to review SMTK’s regulatory disclosures more efficiently.

Rhea-AI Summary

SmartKem, Inc. registers 126,453,978 shares of Common Stock for resale by selling stockholders, comprised of 101,910,996 Conversion Shares issuable upon conversion of Series A Convertible Preferred Stock and 24,542,982 Warrant Shares issuable upon exercise of warrants.

The prospectus states the company is not selling any shares for its own account and will not receive proceeds from resales by the selling stockholders, although SmartKem will receive net proceeds from any warrants exercised for cash. The filing summarizes related financings including an equity line purchase agreement providing up to $500,000,000 or 19.99% of outstanding shares (whichever is less), senior secured notes with an original principal of $3,750,000 and related security interests, and a settlement involving a $300,000 cash payment and assignment of certain patents.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

SmartKem, Inc. registers up to 146,776,707 shares of common stock for resale by Keystone Capital Partners, LLC under a March 30, 2026 Purchase Agreement. These shares may be issued to Keystone at the Company's discretion and then resold by Keystone. The Purchase Agreement includes a maximum committed purchase of up to $500 million or 19.99% of outstanding common stock at the time of the agreement, subject to Nasdaq limits and other conditions. The prospectus states the Company will not receive proceeds from resales by Keystone via this registration, though the Company may receive proceeds if it elects to sell shares to Keystone under the Purchase Agreement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Summary

SmartKem, Inc. announced that a Nasdaq Hearings Panel has determined the company has regained compliance with the stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(2) and meets all other criteria for continued listing on The Nasdaq Capital Market.

The company still has until September 1, 2026 to regain compliance with the minimum bid price requirement in Nasdaq Listing Rule 5550(a)(2). SmartKem will also be under a one-year Discretionary Panel Monitor, meaning any new compliance failure during this period could trigger an immediate delisting determination, though the company would be able to appeal and request a new hearing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

SmartKem, Inc. filed an amended current report to correct details of its recent Series A preferred stock financing. The amendment clarifies that investors received warrants to purchase up to 24,542,982 shares of common stock and that the warrant exercise price is $0.5812 per share.

The filing also reiterates that the company agreed in a private placement to sell 11,411.5 shares of newly designated Series A Convertible Preferred Stock, each with a stated value of $1,000. These preferred shares are convertible into common stock at an initial conversion price of $0.5812 per share, subject to adjustment under the related certificate of designations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

SmartKem, Inc. reported that on April 10, 2026 it accepted the voluntary resignation of Simon Ogier as Chief Technology Officer of subsidiary SmartKem Ltd., effective April 13, 2026. The company stated that his resignation is not due to any dispute or disagreement over financial statements, internal controls, operations, policies, or practices.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

SmartKem, Inc. is registering 126,453,978 shares of Common Stock for resale by selling stockholders, comprised of 101,910,996 Conversion Shares issuable upon conversion of newly designated Series A Convertible Preferred Stock and 24,542,982 Warrant Shares issuable upon exercise of warrants. The company itself is not selling shares here and will not receive proceeds from resales; however, SmartKem will receive net proceeds from any Warrants exercised for cash. The prospectus discloses an equity line with Keystone allowing up to $500,000,000 or 19.99% of outstanding shares (reduced by certain issuances), a senior secured notes financing with original principal $3,750,000 (issued at a ~30% discount), and related settlement and patent assignments tied to prior notes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration
-
Rhea-AI Summary

SmartKem, Inc. is registering up to 146,776,707 shares of common stock for resale by Keystone Capital Partners under a committed equity purchase agreement.

SmartKem may sell shares to Keystone over time for up to the lesser of $500 million and 19.99% of shares outstanding on March 30, 2026, subject to Nasdaq limits and a 4.99% beneficial ownership cap. Common stock outstanding was 21,202,911 shares as of April 13, 2026, and would be 167,979,618 shares if all registered shares are issued. SmartKem will receive no proceeds from Keystone’s resales, but could receive up to $500 million in gross proceeds from primary sales to Keystone, earmarked for working capital and general corporate purposes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration
Rhea-AI Summary

SmartKem, Inc. is a development-stage semiconductor materials company focused on its TRUFLEX® organic thin-film transistor platform for next‑generation displays and advanced chip packaging. It designs inks and processes in the U.K. and collaborates with partners in Taiwan and China on MicroLED backlights, AMOLED displays, biometric sensors and advanced packaging applications.

The company has generated no commercial-scale revenue and remains deeply loss‑making, with a $13.0 million comprehensive loss in 2025 and an accumulated deficit of $125.1 million. Cash and cash equivalents were $0.4 million as of December 31, 2025, which management believes is insufficient to fund operations for at least 12 months, raising substantial doubt about its ability to continue as a going concern and underscoring a need for additional capital.

During early 2026 SmartKem completed several financing transactions that included transferring its patent portfolio to a third party, while retaining process and formulation know‑how in 40 trade secrets. The company is reviewing its strategy, including display prototyping and materials formulation, and continues to build out collaborations and EDA tools to support future commercialization of its materials.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
annual report

FAQ

How many Smartkem (SMTK) SEC filings are available on StockTitan?

StockTitan tracks 44 SEC filings for Smartkem (SMTK), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Smartkem (SMTK)?

The most recent SEC filing for Smartkem (SMTK) was filed on April 27, 2026.